tradingkey.logo
tradingkey.logo
Search

Transmedics Group Inc

TMDX
Add to Watchlist
67.850USD
+1.430+2.15%
Close 07/01, 16:00ETQuotes delayed by 15 min
2.34BMarket Cap
13.44P/E TTM

Transmedics Group Inc

67.850
+1.430+2.15%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

+2.15%

5 Days

-8.10%

1 Month

+0.97%

6 Months

-44.23%

Year to Date

-44.23%

1 Year

-49.37%

Key Figures
67.680Open
71.670High
1.06MVolume
13.44P/E TTM
17.23P/E Dynamic
--Dividend TTM
3.06%Turnover Ratio
66.420Prev. Close
67.440Low
54.50MTurnover
66.09P/E Static
4.74P/B
0.00%Div Yield TTM
15.13%ROA
156.00052wk High
0.64Volume Ratio
35.46MNet Profit
34.55MShares
5.0490EPS TTM
1.94Beta
45.22%ROE
60.10552wk Low
6.37%Amplitude
58.16%Gross Margin
2.34BMarket Cap
-0.94Reward/Risk
3.17%Risk Rate

Key Insights

Transmedics Group Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 55 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 123.10.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Transmedics Group Inc's Score

Industry at a Glance

Industry Ranking
55 / 204
Overall Ranking
131 / 4569
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Transmedics Group Inc Highlights

StrengthsRisks
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 150.59% year-on-year.
Fairly Valued
The company’s latest PE is 13.16, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 42.29M shares, decreasing 3.95% quarter-over-quarter.
Held by John Hussman
Star Investor John Hussman holds 44.62K shares of this stock.

Analyst Rating

Based on 13 analysts
Buy
Current Rating
123.100
Target Price
+85.34%
Upside Space

Transmedics Group Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Transmedics Group Inc Info

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Ticker SymbolTMDX
CompanyTransmedics Group Inc
CEOHassanein (Waleed H)
Websitehttps://www.transmedics.com/

FAQs

What is the current price of Transmedics Group Inc (TMDX)?

The current price of Transmedics Group Inc (TMDX) is 66.42.

What is the symbol of Transmedics Group Inc?

The ticker symbol of Transmedics Group Inc is TMDX.

What is the 52-week high of Transmedics Group Inc?

The 52-week high of Transmedics Group Inc is 156.00.

What is the 52-week low of Transmedics Group Inc?

The 52-week low of Transmedics Group Inc is 60.10.

What is the market capitalization of Transmedics Group Inc?

The market capitalization of Transmedics Group Inc is 2.30B.

Is Transmedics Group Inc (TMDX) currently rated as Buy, Hold, or Sell?

According to analysts, Transmedics Group Inc (TMDX) has an overall rating of Buy, with a price target of 123.10.

What is the Earnings Per Share (EPS TTM) of Transmedics Group Inc (TMDX)?

The Earnings Per Share (EPS TTM) of Transmedics Group Inc (TMDX) is 5.60.